Works matching IS 16187598 AND DT 2004 AND VI 5 AND IP 2
Results: 15
Genetic screening, health care and the insurance industry: Should genetic information be made available to insurers?
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 116, doi. 10.1007/s10198-003-0213-2
- By:
- Publication type:
- Article
An empirical analysis of the demand for physician services across the European Union.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 150, doi. 10.1007/s10198-003-0215-0
- By:
- Publication type:
- Article
Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine: Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 143, doi. 10.1007/s10198-003-0216-z
- By:
- Publication type:
- Article
Economic growth, longevity and the epidemiological transition.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 166, doi. 10.1007/s10198-003-0219-9
- By:
- Publication type:
- Article
Pricing of pharmaceuticals: Assessing the pricing potential by a pricing matrix model.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 110, doi. 10.1007/s10198-003-0209-y
- By:
- Publication type:
- Article
Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 129, doi. 10.1007/s10198-003-0211-4
- By:
- Publication type:
- Article
Dynamic competition in pharmaceuticals: Patent expiry, generic penetration, and industry structure.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 175, doi. 10.1007/s10198-003-0218-x
- By:
- Publication type:
- Article
The risk-adjusted vision beyond casemix (DRG) funding in Australia: International lessons in high complexity and capitation.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 95, doi. 10.1007/s10198-003-0208-z
- By:
- Publication type:
- Article
Increasing value for money in health systems.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 91, doi. 10.1007/s10198-004-0240-7
- By:
- Publication type:
- Article
“Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life?
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 188, doi. 10.1007/s10198-004-0226-5
- By:
- Publication type:
- Article
The European Network of Health Economic Evaluation Databases (EURO NHEED) Project.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 183, doi. 10.1007/s10198-003-0207-0
- By:
- Publication type:
- Article
The risk-adjusted vision beyond casemix (DRG) funding in Australia: International lessons in high complexity and capitation.
- Published in:
- 2004
- By:
- Publication type:
- Erratum
Pricing and reimbursement of drugs in Ireland.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 190, doi. 10.1007/s10198-004-0225-6
- By:
- Publication type:
- Article
Potential cost-effectiveness of a family-based program in mild Alzheimer’s disease patients.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 136, doi. 10.1007/S10198-003-0214-1
- By:
- Publication type:
- Article
Price-cost margin in the pharmaceutical industry: Empirical evidence from Finland.
- Published in:
- European Journal of Health Economics, 2004, v. 5, n. 2, p. 122, doi. 10.1007/S10198-003-0212-3
- By:
- Publication type:
- Article